Clover Health Investments (NASDAQ:CLOV – Get Rating) is one of 13 public companies in the “Hospital & medical service plans” industry, but how does it contrast to its peers? We will compare Clover Health Investments to related businesses based on the strength of its profitability, risk, earnings, valuation, analyst recommendations, institutional ownership and dividends.
Volatility and Risk
Clover Health Investments has a beta of 1.64, meaning that its share price is 64% more volatile than the S&P 500. Comparatively, Clover Health Investments’ peers have a beta of 1.04, meaning that their average share price is 4% more volatile than the S&P 500.
This table compares Clover Health Investments and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Clover Health Investments||-39.93%||-97.71%||-45.48%|
|Clover Health Investments Competitors||-5.34%||-3.70%||-4.00%|
Insider & Institutional Ownership
18.1% of Clover Health Investments shares are owned by institutional investors. Comparatively, 88.0% of shares of all “Hospital & medical service plans” companies are owned by institutional investors. 1.5% of shares of all “Hospital & medical service plans” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Earnings and Valuation
This table compares Clover Health Investments and its peers top-line revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Clover Health Investments||$1.47 billion||-$587.76 million||-2.20|
|Clover Health Investments Competitors||$71.33 billion||$2.57 billion||6.15|
Clover Health Investments’ peers have higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
This is a breakdown of current ratings and recommmendations for Clover Health Investments and its peers, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Clover Health Investments||3||3||2||0||1.88|
|Clover Health Investments Competitors||108||1135||2309||51||2.64|
Clover Health Investments currently has a consensus target price of $6.38, suggesting a potential upside of 103.03%. As a group, “Hospital & medical service plans” companies have a potential upside of 2.05%. Given Clover Health Investments’ higher probable upside, equities research analysts plainly believe Clover Health Investments is more favorable than its peers.
Clover Health Investments peers beat Clover Health Investments on 11 of the 13 factors compared.
About Clover Health Investments (Get Rating)
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.